Brain Gaze

Braingaze is a digital health company that develops clinically validated eye-tracking tools for the diagnosis( treatment( and monitoring of ADHD and other neurodevelopmental conditions( The company uses involuntary eye movement biomarker analysis powered by AI to provide objective diagnostic support( Its flagship product( BGaze Clinic( is a 12-minute eye-tracking-enabled test covering symptoms and neural markers that delivers up to 92% diagnostic accuracy( with automated questionnaires sent to up to 6 informants( and compliance with DSP Toolkit cybersecurity standards( The company also offers BGaze Focus( a suite of gaze-controlled games designed to reduce symptoms of ADHD( autism( and dyslexia( playable on mobile devices without specialized hardware( Braingaze was a spin-off from the University of Barcelona( founded in 2013( and has supported over 6(000 diagnoses with 20-plus peer-reviewed clinical studies(Founded in 2013 and headquartered in London( United Kingdom with operations in Barcelona( Spain( the company has raised $2.2M in seed funding from investors including EIT Health( EIC Fund( Europa( RYSE Asset Management( Artesian( Orbit Ventures( Startup Scaleup(and Chinaccelerator.